A global trial has begun for the world’s first personalized vaccine for melanoma—the deadliest form of skin cancer, which affects about 132,000 people per year. If successful, the therapy will prevent melanoma from returning in patients who have already been treated.
Latest News
Dermatologists warn of dangers of unregulated cosmetic laser industry
Dermatologists are warning of the dangers of the unregulated cosmetic laser industry after a woman’s melanoma was mistaken for a sunspot.
Fact vs. Fiction: Debunking Common Misconceptions about Skin Cancer, Sun Safety
ATLANTA, April 30, 2024 – In the United States, more than 5 million cases of skin cancers are diagnosed each year. Despite its prevalence, there are still a number of misconceptions surrounding the disease.
Personalised mRNA vaccines: a revolutionary new approach in melanoma treatment
A personalised mRNA vaccine to treat melanoma has now reached late-stage trials in the UK. This is just the latest step in improving the cure rate of cancer.